Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
12.65
+0.23 (1.85%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Spyre Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.